相关实验视频

Updated: Jun 6, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

伊索金基基丁抑制RANKL诱导的骨质结晶生成,并缓解骨质损失

Zihe Wang¹, Wei Deng², Kai Tang²

¹Guangzhou University of Chinese Medicine, China; The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, China; The Third School of Clinical Medicine of Guangzhou University of Chinese Medicine, China.

Biochemical pharmacology

|November 29, 2024

概括

伊索金基基丁 (IGG) 有效地抑制骨质细胞的形成和活动,这对于治疗骨质疏松症至关重要. 这种化合物通过向关键信号通路和氧化应激,减少骨质流失并改善骨密度.

科学领域:

生物化学生化学
细胞生物学细胞生物学
药理学药理学是指药理学的学科.

背景情况:

骨质疏松症是一种骨疾病,其特点是骨质细胞活性较高,导致骨质损失和骨折风险增加.
了解抑制骨质细胞形成的分子机制对于开发有效的骨质疏松症治疗至关重要.

研究的目的:

研究伊索金克基丁 (IGG) 对骨质细胞形成的抑制作用和潜在机制.
评估IGG作为治疗骨质疏松症的治疗剂的潜力.

主要方法:

使用骨髓衍生的巨细胞 (BMM) 进行体外研究,以评估IGG对骨质细胞分化和功能的影响 (TRAP分析).
在体内验证骨质疏松症模型使用Micro-CT和免疫组织化学.
分子分析包括RT-PCR和Western Blot,以检查MAPK和NF-κB通路中的基因和蛋白质表达,以及氧化应激标志物.

主要成果:

在高达10μM的度下,IGG没有对BMM表现出细胞毒性.
IGG显著抑制了骨质结晶发生,骨质再吸收和关键骨质结晶发生基因和蛋白质的表达.
IGG通过抑制P38,ERK和P65酸化和拯救IκB-α降解来调节MAPK和NF-κB信号通路.
IGG影响了氧化应激标志物 (SOD-1,HO-1,catalase) 并在体内减弱了骨质损失,改善了脊椎骨参数.

结论:

异构基因基因 (IGG) 通过调节MAPK和NF-κB通路和氧化应激,有效地抑制骨质细胞形成和骨质再吸收.
通过保持骨密度和减少骨质损失,IGG显示了骨质疏松症管理的治疗潜力.

关键词:

我认为我会得到它.骨质细胞生成 (Osteoclastogenesis) 是一个过程.他们的排名是Rank.兰克尔 (Rankl) 是一个名字.在SPR中使用SPR.

更多相关视频

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

相关概念视频

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...